Albright

Prokarium Achieves Major Milestone with FDA's IND Approval for Bladder Cancer Program

Retrieved on: 
Thursday, November 2, 2023
Oncology, FDA, Health, Clinical Trials, Pharmaceutical, Biotechnology, Vanderbilt-Ingram Cancer Center, Achilles, IND, Food, Evotec, MD, Bladder cancer, GSK plc, Doctor of Philosophy, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Albright, Doctor of Pharmacy, Recurrence, Immunotherapy, Therapy, BCG, Synthetic biology, Patient, Cancer, Investigational New Drug, Pharmaceutical industry

Prokarium, a biopharmaceutical company at the forefront of applying synthetic biology to create novel cancer treatments, today announces that the U.S. Food and Drug Administration (FDA) has granted the company's Investigational New Drug (IND) application for their immunotherapy ZH9.

Key Points: 
  • Prokarium, a biopharmaceutical company at the forefront of applying synthetic biology to create novel cancer treatments, today announces that the U.S. Food and Drug Administration (FDA) has granted the company's Investigational New Drug (IND) application for their immunotherapy ZH9.
  • The approval enables initiation of the clinical development program for ZH9 in the U.S., focusing on patients with non-muscle invasive bladder cancer.
  • "The FDA’s approval of our IND application is an important milestone and a clear recognition of the preclinical data already generated for ZH9,” stated Prokarium’s CEO, Kristen Albright, PharmD.
  • Dara brings over two decades of experience in biotech and large pharma.

Inszone Insurance Services Strengthens Presence in Southern California with Acquisition of Titan Global Insurance Brokerage Inc.

Retrieved on: 
Tuesday, September 19, 2023
Insurance, Professional Services, Albright, Insurance Services of America, Acquisition, Financial services, Titan

Inszone Insurance Services, a rapidly growing national provider of benefits, personal, and commercial lines insurance, has announced the acquisition of Titan Global Insurance Brokerage Inc., a well-established independent brokerage with nearly two decades of experience.

Key Points: 
  • Inszone Insurance Services, a rapidly growing national provider of benefits, personal, and commercial lines insurance, has announced the acquisition of Titan Global Insurance Brokerage Inc., a well-established independent brokerage with nearly two decades of experience.
  • Founded in October 2007 by Brent Albright, Titan Global Insurance Brokerage has been instrumental in serving businesses with unique insurance needs.
  • "We are thrilled to announce the successful acquisition of Titan Global Insurance Brokerage," said Chris Walters, CEO of Inszone Insurance Services.
  • With this acquisition, Inszone Insurance Services gains access to a wealth of industry knowledge and expertise, particularly in workers' compensation and general commercial insurance.

CSX Announces Departure of Operations Executive Jamie Boychuk

Retrieved on: 
Friday, August 4, 2023
Growth, Albright, Service, CSX, Transport, Culture, Safety, Management, Operation, Hinrichs

JACKSONVILLE, Fla., Aug. 04, 2023 (GLOBE NEWSWIRE) -- CSX (NASDAQ: CSX) announced today that Jamie Boychuk, executive vice president of Operations, is leaving the company.

Key Points: 
  • JACKSONVILLE, Fla., Aug. 04, 2023 (GLOBE NEWSWIRE) -- CSX (NASDAQ: CSX) announced today that Jamie Boychuk, executive vice president of Operations, is leaving the company.
  • President and Chief Executive Officer Joe Hinrichs thanked Boychuk for his role in the implementation of scheduled railroading and cited the company’s depth of operational experience that will ensure continuity while CSX searches for a successor.
  • Johnson, who oversees all field operations, has over 30 years of experience in the railroad industry, including 22 years of service at CSX.
  • In his current position, he oversees fluid traffic flow across the CSX network, leading the design of service plans that support performance improvement and meet customer needs.

Karen Albright, CEO of BodyLase Med Spa, Appointed President of Entrepreneurs Organization (EO) Raleigh-Durham Chapter

Retrieved on: 
Thursday, June 29, 2023
Chapter, Growth, Albright, EO, Environment, Entrepreneurs' Organization, Creative industries, Management

RALEIGH, N.C., June 29, 2023 /PRNewswire/ -- BodyLase Med Spa announces that Karen Albright, CEO and founder, has been named incoming Chapter President, effective July 2023, of the Entrepreneurs Organization (EO) Raleigh-Durham Chapter.

Key Points: 
  • RALEIGH, N.C., June 29, 2023 /PRNewswire/ -- BodyLase Med Spa announces that Karen Albright, CEO and founder, has been named incoming Chapter President, effective July 2023, of the Entrepreneurs Organization (EO) Raleigh-Durham Chapter.
  • Albright has been an esteemed member of EO since 2017, actively contributing to the vibrant entrepreneurial community within the organization.
  • "I am thrilled to embark on this new role as President of the Entrepreneurs Organization Raleigh-Durham Chapter," Albright exclaims.
  • Under Albright's leadership, the EO Raleigh-Durham Chapter anticipates continued growth, fostering an environment where entrepreneurs can flourish, exchange ideas, and overcome challenges together.

SWK Holdings Appoints Jerry Albright to Board of Directors

Retrieved on: 
Wednesday, March 15, 2023
SWK, Advisory board, Ministry of Finance, Retirement, Chairperson, H5 (US company), Economics, Executive, Texas A&M University, Albright, Teacher Retirement System of Texas, TRS, Finance department, Punjab (Pakistan), Management

DALLAS, March 15, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that Jerry Albright has been named to the Company's Board of Directors and will replace Wendy DiCicco, who chose not to seek re-election to the Board because of external professional commitments.

Key Points: 
  • DALLAS, March 15, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announced that Jerry Albright has been named to the Company's Board of Directors and will replace Wendy DiCicco, who chose not to seek re-election to the Board because of external professional commitments.
  • The transition will be effective March 15, 2023, with Mr. Albright joining Board Chair, Laurie Dotter, and directors, Robert K. Hatcher, and Marcus Pennington, on the Board.
  • "We believe Jerry's expertise in board protocols and practices should allow for a seamless transition from Ms. DiCicco, who has served on our Board since February 2022.
  • Mr. Albright has also previously served on the Advisory Board of the Finance Department at Texas A&M University.

Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

Retrieved on: 
Thursday, February 9, 2023
Biotechnology, Pharmaceutical, Health, Oncology, MBA, Synthetic biology, Francis Crick Institute, Immunotherapy, Ginkgo Bioworks, Cancer, Vanderbilt-Ingram Cancer Center, Principal Group, Doctor of Pharmacy, RNA, Bladder cancer, Codebase, Salmonella, Partnership, Bacillus, Albright, BCG, Doctor of Philosophy, MD, Vaccine

Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised $30 million in new funding.

Key Points: 
  • Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised $30 million in new funding.
  • This follows Prokarium’s announcement of partnering with Ginkgo Bioworks to leverage its world-class Foundry and extensive Codebase to develop a bactofection platform technology.
  • “We are excited to advance our vision to create living cures,” said Kristen Albright, PharmD, Chief Executive Officer of Prokarium.
  • “Proceeds of this financing will fund our lead oncology program entering clinical development this year and enable platform expansion for the delivery of novel therapeutic payloads, including RNA, via our proprietary bacteria.

Lex Machina Releases 2023 Patent Litigation Report

Retrieved on: 
Wednesday, February 15, 2023
LexisNexis, Fish & Richardson, Samsung, Woodsford, Patent Trial and Appeal Board, Software, Research, White v. Samsung Electronics America, Inc., ANDA, Lex Machina, Albright, PTAB, Generic drug, Mobile phone, Patent

MENLO PARK, Calif., Feb. 15, 2023 /PRNewswire/ -- Lex Machina, a LexisNexis company, today releases its annual Patent Litigation Report. The report examines trends in patent litigation in federal district courts, appellate courts, and the Patent Trial and Appeal Board (PTAB). Focusing on the three-year period from 2020 to 2022, it surveys emerging trends in case filings, venues, judges, law firms, parties, timing metrics, case resolutions, findings, and damages. The report often focuses on different sets of data, e.g., filtering cases in order to provide analytics on ANDA, PTAB, and federal appellate cases.

Key Points: 
  • While Judge Albright and the Western District of Texas continued to hold onto their leads with the highest numbers of filed patent cases, the data revealed distinct drops in their cases in 2022
    MENLO PARK, Calif., Feb. 15, 2023 /PRNewswire/ -- Lex Machina, a LexisNexis company, today releases its annual Patent Litigation Report.
  • The report examines trends in patent litigation in federal district courts, appellate courts, and the Patent Trial and Appeal Board (PTAB).
  • "In the practice area of patent litigation, there's been a lot of discussion and analyses of Judge Albright and the Western District of Texas in recent years," said Elaine Chow, Lex Machina's patent legal data expert and editor of the report.
  • Register here for a copy of the report: https://pages.lexmachina.com/2023PatentReport_LP.html
    Lex Machina is hosting a webcast to discuss the report on February 15, 2023 at noon ET/9am PT with Michael Connelly (President of WIT Legal), Robin Davis (Chief Investment Officer at Woodsford), Elaine Chow (Lex Machina's Legal Data Expert in Patent Litigation), and Aria Nejad (Lex Machina's in-house counsel).

Beverly Hills Publishing™ leads the publishing industry with a High-end 360-publishing experience to release books within 90 days

Retrieved on: 
Wednesday, December 21, 2022
Crypto, Albright, PR, Depression, Marketing, LOS, Life, Mayhem, Publishing, MD, Book, Trust (social science), Philanthropy, Dream, Magic Circle (law firms), Physician, Film, Entrepreneurship

LOS ANGELES, Dec. 21, 2022 /PRNewswire/ -- Beverly Hills Publishing™, led by Andréa Albright, known as The Media Disruptor, a High-End Luxury Book Publishing, Marketing, PR, and Hollywood Distribution company that takes your story from book to multi-media production is creating the next movement for authors and helping evolve the publishing industry.

Key Points: 
  • Beverly Hills Publishing™ Andréa Albright is helping evolve the publishing industry with a 90-day strategy to release books.
  • Beverly Hills Publishing™ is known for working exclusively with thought leaders who know their book is more than just a book.
  • Andréa Albright, "The Media Disruptor," created Beverly Hills Publishing™ in a bunk bed after the most heart-wrenching blow of her entire life.
  • Beverly Hills Publishing™, a High-End Luxury Book Publishing, Marketing, PR, and Hollywood Distribution company that takes your story from book to multi-media production.

CSV Midstream Solutions Corp. Announces Final Investment Decision for Albright Sour Gas Processing Plant

Retrieved on: 
Tuesday, October 25, 2022
Albright, Natural gas, FID, Completion, CSV, Montney, British Columbia, Sulfur, NGL, GLOBE, Solution, Oil, Management, Petroleum, Engineering, Wembley, Beaverlodge

CALGARY, Alberta, Oct. 25, 2022 (GLOBE NEWSWIRE) -- CSV Midstream Solutions Corp. (CSV) is pleased to announce a final investment decision (FID) to proceed with its Albright Sour Gas Processing Facility (Albright) to be constructed near Grande Prairie, Alberta.

Key Points: 
  • CALGARY, Alberta, Oct. 25, 2022 (GLOBE NEWSWIRE) -- CSV Midstream Solutions Corp. (CSV) is pleased to announce a final investment decision (FID) to proceed with its Albright Sour Gas Processing Facility (Albright) to be constructed near Grande Prairie, Alberta.
  • With the recent announcement, CSV is looking forward to the positive social impact Albright will have on the region.
  • About CSV Midstream Solutions Corp.
    CSV Midstream is a Calgary-based company offering a full suite of services for complete midstream solutions.
  • CSV Midstreams primary focus is the developing natural gas energy industry in the Western Canadian Sedimentary Basin.

Financial Advisor Chris Albright Joins LPL Financial, Forms Partnership to Strengthen Practice

Retrieved on: 
Tuesday, October 18, 2022
Albright, Financial institution, RIA, Communication, Growth, Financial plan, Investment, Partnership, Nasdaq, AUM, Technology, Goal, Acquisition, Industry, LPLA, Business development, GLOBE, Astra, LPL Financial, LPL, Financial adviser, Financial services

CHARLOTTE, N.C., Oct. 18, 2022 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that financial advisor Chris Albright of Astra Wealth Advisors has joined LPL Financials broker-dealer, RIA and custodial platforms.

Key Points: 
  • CHARLOTTE, N.C., Oct. 18, 2022 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that financial advisor Chris Albright of Astra Wealth Advisors has joined LPL Financials broker-dealer, RIA and custodial platforms.
  • He reported having served approximately $192 million in advisory, brokerage and retirement assets*, and joins LPL from Wells Fargo Financial Advisors Network.
  • With the move, Albright will partner with current LPL affiliated advisor Kimberly Santarsiero in an effort to strengthen his practice and expand services to clients.
  • Throughout this communication, the terms financial advisors and advisors are used to refer to registered representatives and/or investment advisor representatives affiliated with LPL Financial LLC.